STAT Plus: Cancer startup aims precision medicine at rare genetic driver
ANNE WESTON/FRANCIS CRICK INSTITUTE/WELLCOME
A company focused on precision medicine to treat cancer patients with rare gene fusions launched with funding, a study, and a sequencing deal.
.png)
No hay comentarios:
Publicar un comentario